min luo

Dr. min luo


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 November 2024 in The Chemical Record
Verified
Journal Article
Closed access
MLmin luo
min luo
FZFu‐Kun Zhao
Fu‐Kun Zhao
YWYuan‐Min Wang
Yuan‐Min Wang
YLYong Luo
Yong Luo

25 November 2024 in Journal of Cellular and Molecular Medicine
Verified
Journal Article
Open access
PDF file
LLLing Ling
Ling Ling
MLmin luo
min luo
HYHaolin Yin
Haolin Yin
YTYunyun Tian
Yunyun Tian
TWTao Wang
Tao Wang
JBJiang Bian
Jiang Bian
Sinomenine (SIN), a bioactive isoquinoline alkaloid extracted from the roots and stems of Sinomenium acutum, is efficacious against various chronic pain conditions. Inhibition of microglial activation at the spinal level contributes to the analgesic effects of SIN. Microglial activation in the spinal dorsal horn is key to sensitising neuropathic pain. Consequently, this study aimed to investigate whether the antinociceptive effects of SIN in neuropathic pain are induced through microglial inhibition and the underlying mechanisms. In this study, we observed that SIN alleviated chronic constriction injury (CCI)–induced pain hypersensitivity, spinal microglial activation and neuroinflammation. Consistently, SIN evoked the upregulation of transforming growth factor‐beta1 (TGF‐β1) and phosphorylated Smad3 in the L4–6 ipsilateral spinal dorsal horn of CCI mice. Intrathecal injection of TGF‐β1 siRNA and an activin receptor‐like receptor (ALK5) inhibitor reversed SIN's antinociceptive and antimicroglial effects on CCI mice. Moreover, targeting Smad3 in vitro with siRNA dampened the inhibitory effect of TGF‐β1 on lipopolysaccharide‐induced microglial activation. Finally, targeting Smad3 abrogated SIN‐induced pain relief and microglial inhibition in CCI mice. These findings indicate that the TGF‐β1/ALK5/Smad3 axis plays a key role in the antinociceptive effects of SIN on neuropathic pain, indicating its suppressive ability on microglia.

22 June 2024 in Heliyon
Verified
Journal Article
Open access
MLmin luo
min luo
CZCheng Zhao
Cheng Zhao
YZYanhua Zhao
Yanhua Zhao
YWYin Wang
Yin Wang
MLMin - Luo
Min - Luo
Homer protein homolog 3 (HOMER3), a factor implicated in both physiological and pathological processes, has been studied extensively to determine the relationship between its expression level and the prognosis of various malignancies. However, the significance and clinicopathological role of HOMER3 in colorectal adenocarcinoma remain unclear. In this study, bioinformatics techniques were used to find the correlation between high HOMER3 expression levels and clinicopathological features of colorectal adenocarcinoma (COAD) patients. Cellular experiments confirmed the differential expression of HOMER3 in tumor cells compared to normal cells. HOMER3 overexpression was significantly associated with COAD staging and carcinoembryonic antigen (CEA) levels. Patients with high HOMER3 expression levels have a poor prognosis. HOMER3 expression levels can be distinguished more accurately between tumor and non-tumor tissues (AUC = 0.634). The HOMER3 gene variation rate in COAD tissue was 0.7 %. Moreover, 16 of the 22 DNA methylation sites in HOMER3 were associated with COAD prognosis. Our findings confirmed that HOMER3 was positively correlated with immune cell infiltration and immune checkpoints (PD-1, CTLA-4, LMTK3, and LAG3) in COAD, Specifically, we will clearly state that while there is statistical significance, the actual strength of the correlations is weak. During KEGG enrichment analysis, HOMER3 was enriched along with DLG4 and SHANK1 in glutamatergic synapses. Additionally, upstream microRNAs that could bind to HOMER3 were predicted. These findings suggest that HOMER3 might be involved in COAD development and immune regulation. HOMER3 acts as a potential biomarker that can facilitate innovative developments in the diagnosis and prognostic assessment of COAD.

24 August 2026 in Frontiers in Pharmacology
Verified
Journal Article
Open access
PDF file
YWYuan-Min Wang
Yuan-Min Wang
FZFu-Kun Zhao
Fu-Kun Zhao
COCang-Hong Ou-Yang
Cang-Hong Ou-Yang
RZRong-Ping Zhu
Rong-Ping Zhu
MLmin luo
min luo
Background: Hypokalemia is a common adverse event during piperacillin/tazobactam (TZP) therapy in critically ill patients. This study developed and externally validated machine learning models to predict hypokalemia using baseline variables. Methods: Data were obtained from the Medical Information Mart for Intensive Care (MIMIC)-IV database and an external cohort from the Third Affiliated Hospital of Zunyi Medical University. Hypokalemia was defined as the first serum potassium 20% missing data were excluded; remaining missing values were imputed. Least Absolute Shrinkage and Selection Operator (LASSO) regression with 10-fold cross-validation based on binomial deviance was used for feature selection. Logistic Regression, Random Forest, Extreme Gradient Boosting Model (XGBoost), Adaptive Boosting (AdaBoost), and Gradient Boosting Machine models were developed. Performance was assessed with receiver operating characteristic curves, the area under the receiver operating characteristic curve (AUC), the area under the precision-recall curve (AUPRC), calibration, precision-recall analysis, and decision curve analysis. Results: The internal cohort included 1,345 patients (594 hypokalemia), and the external cohort included 421 patients (159 hypokalemia). Internal AUCs were 0.759 (Random Forest), 0.738 (GBM), 0.735 (XGBoost), 0.716 (AdaBoost), and 0.694 (Logistic Regression). External AUCs were 0.668 (GBM), 0.654 (XGBoost), 0.648 (Random Forest), 0.645 (AdaBoost), and 0.620 (Logistic Regression). The Random Forest model achieved an AUPRC of 0.701 in the internal cohort, while GBM achieved the highest AUPRC in the external cohort (0.554). Calibration and decision curve analyses demonstrated acceptable agreement and potential clinical utility. SHapley Additive exPlanations (SHAP) analysis identified baseline potassium, potassium-wasting diuretic use, serum creatinine, age, renal disease, serum sodium, and albumin as the most influential predictors of TZP-associated hypokalemia. Conclusion: Machine learning models achieved moderate predictive performance. Baseline potassium and potassium-wasting diuretic use were the strongest predictors.

9 January 2026 in Medicine
Verified
Journal Article
Open access
MLmin luo
min luo
YZYue Zhang
Yue Zhang
PLPei-Feng Li
Pei-Feng Li
Colorectal cancer (CRC) represents one of the most prevalent malignancies within the gastrointestinal tract, with both its incidence and mortality rates exhibiting a steady rise in recent years. This trend underscores the critical need for identifying reliable biomarkers to predict disease progression, guide treatment strategies, and improve prognostic outcomes. The histone family, comprising essential proteins that bind to DNA, plays a pivotal role in transcriptional regulation and gene expression. Among these, Histone Cluster 2 H2A Family Member C14 (H2AC14) belongs to the histone H2A family. Despite its potential significance, no studies have yet explored the role of H2AC14 in CRC. To address this gap, we employed bioinformatics analysis to investigate the potential involvement of H2AC14 in CRC treatment and prognosis. Analysis of The Cancer Genome Atlas-Colon Adenocarcinoma database revealed that H2AC14 is significantly overexpressed in CRC, with its expression levels correlating with TNM staging, prognosis, and overall survival. However, the mechanistic role of H2AC14 CRC remains unexplored. To validate its functional relevance, we utilized CRC cell lines (LOVO, HT29, HCT116, and SW480) alongside NCM460 normal colon cells. Our findings demonstrated that H2AC14 is highly expressed in CRC. Silencing of the H2AC14 gene resulted in reduced migration speed of CRC and downregulation of genes associated with epithelial–mesenchymal transition, suggesting that H2AC14 promotes the epithelial–mesenchymal transition process, thereby facilitating tumor metastasis. Furthermore, area under curve analysis indicated that H2AC14 possesses diagnostic predictive value for CRC. In summary, H2AC14 emerges as a potential biomarker for CRC, warranting further clinical investigation to elucidate its therapeutic and prognostic implications.